In Alzheimer’s disease (AD), a neurodegenerative disorder characterized by deficient cognitive processes and the accumulation of amyloid precursor protein (APP) and amyloid-β, LRP6 mutations are considered to be pathogenic factors. This evidence concerns the gene LRP6 and early-onset autosomal dominant Alzheimer disease.